Variant · Snv
MLH1 R226*
CI-VAR-00003771Explore in graph →NP_000240.1:p.Arg226TerNM_000249.3:c.676C>TClinVar 17087 CIViC 754 rs63751615
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 25111426
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Malignant Colorectal Neoplasm1 | ||||||||
| MLH1 R226* | (oncogenic) | Oncogenic | C | Supports Oncogenicity | 1 | accepted | EID1818MLH1 R226* (c.676C > T), identified in a case of microsatellite-unstable colorectal cancer, was confirmed to be somatic in a 65 year old female patient (sLS-14) with suspected Lynch Syndrome (LS). The… (full text at CIViC) PMID 25111426 · Geurts-Giele et al., 2014 · Open in CIViC | civic |
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 17087 | Pathogenic | reviewed by expert panel | 3 | Colorectal cancer, hereditary nonpolyposis, type 2; Lynch syndrome; Hereditary cancer-predisposing syndrome; Hereditary nonpolyposis colorectal neoplasms; Lynch syndrome 1; Lynch-like syndrome; Mismatch repair cancer syndrome 1; Muir-Torré syndrome; Breast and/or ovarian cancer; Hereditary nonpolyposis colon cancer; MLH1-related disorder | germline/somatic |